Patents by Inventor Erika Navarro-Sanchez

Erika Navarro-Sanchez has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Chimeric poly peptides and the therapeutic use thereof against a flaviviridae infection
    Patent number: 10227385
    Abstract: The invention relates to building a chimeric polypeptide used for preventing or treating a Flaviviridae infection. The use of the inventive chimeric polypeptide for producing recombinant viral vectors such as a measles living viral vector is also disclosed.
    Type: Grant
    Filed: January 18, 2017
    Date of Patent: March 12, 2019
    Assignees: INSTITUT PASTEUR, CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE
    Inventors: Frederic Tangy, Marianne Lucas-Hourani, Erika Navarro-Sanchez, Marie-Pascale Frenkiel, Hugues Bedouelle, Chantal Combredet, Philippe Despres
  • CHIMERIC POLY PEPTIDES AND THE THERAPEUTIC USE THEREOF AGAINST A FLAVIVIRIDAE INFECTION
    Publication number: 20170121375
    Abstract: The invention relates to building a chimeric polypeptide used for preventing or treating a Flaviviridae infection. The use of the inventive chimeric polypeptide for producing recombinant viral vectors such as a measles living viral vector is also disclosed.
    Type: Application
    Filed: January 18, 2017
    Publication date: May 4, 2017
    Inventors: Frederic TANGY, Marianne LUCAS-HOURANI, Erika NAVARRO-SANCHEZ, Marie-Pascale FRENKIEL, Hugues BEDOUELLE, Chantal COMBREDET, Philippe DESPRES
  • Chimeric poly peptides and the therapeutic use thereof against a Flaviviridae infection
    Patent number: 9579375
    Abstract: The invention relates to building a chimeric polypeptide used for preventing or treating a Flaviviridae infection. The use of the inventive chimeric polypeptide for producing recombinant viral vectors such as a measles living viral vector is also disclosed.
    Type: Grant
    Filed: September 4, 2014
    Date of Patent: February 28, 2017
    Assignees: INSTITUT PASTEUR, CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE
    Inventors: Frederic Tangy, Marianne Lucas-Hourani, Erika Navarro-Sanchez, Marie-Pascale Frenkiel, Hugues Bedouelle, Chantal Combredet, Philippe Despres
  • CHIMERIC POLY PEPTIDES AND THE THERAPEUTIC USE THEREOF AGAINST A FLAVIVIRIDAE INFECTION
    Publication number: 20150071963
    Abstract: The invention relates to building a chimeric polypeptide used for preventing or treating a Flaviviridae infection. The use of the inventive chimeric polypeptide for producing recombinant viral vectors such as a measles living viral vector is also disclosed.
    Type: Application
    Filed: September 4, 2014
    Publication date: March 12, 2015
    Inventors: Frederic TANGY, Marianne LUCAS-HOURANI, Erika NAVARRO-SANCHEZ, Marie-Pascale FRENKIEL, Hugues BEDOUELLE, Chantal COMBREDET, Philippe DESPRES
  • Chimeric poly peptides and the therapeutic use thereof against a flaviviridae infection
    Patent number: 8853379
    Abstract: The invention relates to building a chimeric polypeptide used for preventing or treating a Flaviviridae infection. The use of the inventive chimeric polypeptide for producing recombinant viral vectors such as a measles living viral vector is also disclosed.
    Type: Grant
    Filed: April 19, 2011
    Date of Patent: October 7, 2014
    Assignees: Institut Pasteur, Centre National de la Recherche Scientifique
    Inventors: Frederic Tangy, Marianne Lucas-Hourani, Erika Navarro-Sanchez, Marie-Pascale Frenkiel, Hugues Bedouelle, Chantal Combredet, Philippe Despres
  • Chimeric poly peptides and the therapeutic use thereof against a Flaviviridae infection
    Patent number: 8337857
    Abstract: The invention relates to building a chimeric polypeptide used for preventing or treating a Flaviviridae infection. The use of the inventive chimeric polypeptide for producing recombinant viral vectors such as a measles living viral vector is also disclosed.
    Type: Grant
    Filed: June 20, 2006
    Date of Patent: December 25, 2012
    Assignees: Institut Pasteur, Centre National de la Recherche Scientifique
    Inventors: Frederic Tangy, Marianne Lucas-Hourani, Erika Navarro-Sanchez, Marie-Pascale Frenkiel, Hugues Bedouelle, Chantal Combredet, Philippe Despres
  • CHIMERIC POLY PEPTIDES AND THE THERAPEUTIC USE THEREOF AGAINST A FLAVIVIRIDAE INFECTION
    Publication number: 20120201825
    Abstract: The invention relates to building a chimeric polypeptide used for preventing or treating a Flaviviridae infection. The use of the inventive chimeric polypeptide for producing recombinant viral vectors such as a measles living viral vector is also disclosed.
    Type: Application
    Filed: April 19, 2011
    Publication date: August 9, 2012
    Applicants: CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE, INSTITUT PASTEUR
    Inventors: Frederic TANGY, Marianne Lucas-Hourani, Erika Navarro-Sanchez, Marie-Pascale Frenkiel, Hugues Bedouelle, Chantal Combredet, Philippe Despres
  • CHIMERIC POLY PEPTIDES AND THE THERAPEUTIC USE THEREOF AGAINST A FLAVIVIRIDAE INFECTION
    Publication number: 20100226924
    Abstract: The invention relates to building a chimeric polypeptide used for preventing or treating a Flaviviridae infection. The use of the inventive chimeric polypeptide for producing recombinant viral vectors such as a measles living viral vector is also disclosed.
    Type: Application
    Filed: June 20, 2006
    Publication date: September 9, 2010
    Applicants: INSTITUE PASTEUR, CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE
    Inventors: Frederic Tangy, Marianne Lucas-Hourani, Erika Navarro-Sanchez, Marie-Pascale Frenkiel, Hugues Bedouelle, Chantal Combredet, Philippe Despres